Scholarlink

<p>Atherosclerosis (AS) is the leading cause of global mortality and morbidity. Despite the elevated expression of sodium-hydrogen exchanger 1 (NHE1) and olfactory receptor 2 (Olfr2) in plaque macrophages, their interactions within the AS context remain poorly understood. In this study, ApoE<sup>−/−</sup> mice and RAW264.7 macrophages were employed to examine the impact of intraperitoneal octanal injection on atherosclerosis and NHE1 expression in vivo. In vitro analyses were conducted to assess NHE1 expression, activity, and inflammatory responses subsequent to treatment with octanal and an NHE1 inhibitor. Furthermore, the underlying mechanisms were investigated through RNA interference and calcium ion (Ca2+) chelation. In vivo, octanal aggravated AS by upregulating NHE1 within plaques, while NHE1 deficiency resulted in reduced plaque formation and inflammation. In vitro, octanal increased NHE1 expression and activity in a dose- and time-dependent manner in RAW264.7 cells, facilitating foam cell formation and inflammatory responses. NHE1 inhibitors effectively attenuated these effects. Mechanistically, RNA interference targeting Olfr2 or calcium chelation reduced octanal-induced NHE1 upregulation and associated inflammatory responses. These findings highlight NHE1 as a key downstream effector in the Octanal/Olfr2 signaling pathway, suggesting that targeting NHE1 may present a promising therapeutic approach for AS.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

NHE1 in macrophages promotes octanal/Olfr2-induced atherosclerosis via calcium-dependent ROS and NLRP3 inflammasome activation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月29日

查看全文
  • Tianhui Wang,
  • Lan Wang,
  • Qian Tian,
  • Yuan Zhu,
  • Lijuan Shao,
  • Jiao Zeng,
  • Yongchao Yu,
  • Zhonglian Li,
  • Xiaomeng Su,
  • Juhai Chen,
  • Ya Zhang,
  • Xiangang Mo

摘要

Atherosclerosis (AS) is the leading cause of global mortality and morbidity. Despite the elevated expression of sodium-hydrogen exchanger 1 (NHE1) and olfactory receptor 2 (Olfr2) in plaque macrophages, their interactions within the AS context remain poorly understood. In this study, ApoE−/− mice and RAW264.7 macrophages were employed to examine the impact of intraperitoneal octanal injection on atherosclerosis and NHE1 expression in vivo. In vitro analyses were conducted to assess NHE1 expression, activity, and inflammatory responses subsequent to treatment with octanal and an NHE1 inhibitor. Furthermore, the underlying mechanisms were investigated through RNA interference and calcium ion (Ca2+) chelation. In vivo, octanal aggravated AS by upregulating NHE1 within plaques, while NHE1 deficiency resulted in reduced plaque formation and inflammation. In vitro, octanal increased NHE1 expression and activity in a dose- and time-dependent manner in RAW264.7 cells, facilitating foam cell formation and inflammatory responses. NHE1 inhibitors effectively attenuated these effects. Mechanistically, RNA interference targeting Olfr2 or calcium chelation reduced octanal-induced NHE1 upregulation and associated inflammatory responses. These findings highlight NHE1 as a key downstream effector in the Octanal/Olfr2 signaling pathway, suggesting that targeting NHE1 may present a promising therapeutic approach for AS.